Apollo Endosurgery Inc. (APEN)
NASDAQ: APEN
· Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Apr 03, 2023, 10:00 PM
Apollo Endosurgery Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 76.86M | 71.71M | 68.49M | 65.79M | 62.99M | 59.68M | 56.15M | 45.19M |
Cost of Revenue | 34.43M | 31.54M | 29.83M | 28.97M | 28.03M | 26.63M | 25.35M | 21.07M |
Gross Profit | 42.43M | 40.17M | 38.66M | 36.83M | 34.96M | 33.05M | 30.81M | 24.11M |
Operating Income | -27.82M | -26.3M | -24.51M | -23.17M | -19.68M | -16.75M | -13.82M | -12.87M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -39.26M | -40.35M | -35.64M | -28.21M | -24.53M | -17.51M | -13.5M | -16.8M |
Net Income | -39.84M | -40.69M | -35.9M | -28.5M | -24.68M | -17.78M | -13.72M | -16.96M |
Selling & General & Admin | 56.59M | 53.26M | 50.18M | 47.35M | 42.76M | 38.67M | 34.53M | 27.61M |
Research & Development | 11.91M | 10.91M | 10.68M | 10.31M | 9.52M | 9.23M | 8.19M | 7.45M |
Other Expenses | 1.75M | 1.82M | 1.84M | 1.86M | 1.88M | 1.89M | 1.91M | 1.93M |
Operating Expenses | 70.25M | 65.99M | 62.69M | 59.52M | 54.16M | 49.79M | 44.62M | 36.98M |
Interest Expense | 4.67M | 7.87M | 8.06M | 8.19M | 8.32M | 5.38M | 5.38M | 5.36M |
Selling & Marketing Expenses | 36.01M | 33.33M | 30.86M | 27.74M | 24.31M | 21.5M | 19.55M | 15.81M |
Cost & Expenses | 104.68M | 97.53M | 92.52M | 88.49M | 82.19M | 76.42M | 69.97M | 58.06M |
Income Tax Expense | 584K | 344K | 262K | 284K | 156K | 272K | 223K | 158K |
Shares Outstanding (Basic) | 30.24M | 40.85M | 40.36M | 39.65M | 38.26M | 29.02M | 27.27M | 26.31M |
Shares Outstanding (Diluted) | 30.24M | 40.85M | 40.36M | 39.65M | 38.26M | 29.02M | 27.27M | 26.31M |
EPS (Basic) | -1.07 | -1.02 | -0.97 | -0.82 | -0.78 | -0.64 | -0.52 | -0.71 |
EPS (Diluted) | -1.07 | -1.02 | -0.97 | -0.82 | -0.78 | -0.64 | -0.52 | -0.71 |
EBITDA | -28.41M | -32.71M | -27.86M | -24.67M | -22.16M | -14.69M | -10.48M | -9.54M |
EBIT | -30.98M | -32.47M | -27.58M | -20.02M | -16.21M | -9.1M | -5.09M | -8.41M |
Depreciation & Amortization | -3.8M | -3.18M | 627K | 3.31M | 3.23M | 3.39M | 3.56M | 3.68M |